Revance Therapeutics (RVNC) - basic shares outstanding

Number of shares outstanding as of September 2024 : 103,870,235

According to Revance Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 103,870,235. At the end of 2024 the company had 103,870,235 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Revance Therapeutics from 2013 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.10 B	19.92%
2023	86.61 M	8.1%
2022	80.12 M	17.77%
2021	68.03 M	7.48%
2020	63.29 M	38.73%
2019	45.62 M	25.57%
2018	36.33 M	15.05%
2017	31.58 M	11.98%
2016	28.2 M	6.58%
2015	26.46 M	12.64%
2014	23.49 M	32.39%
2013	17.74 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
MediciNova MNOV	49,046,246	-52.78%	🇺🇸 USA
Johnson & Johnson JNJ	2,406,800,000	2,217.12%	🇺🇸 USA
Biogen BIIB	145,600,000	40.17%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Revance Therapeutics (RVNC)

Number of shares outstanding as of September 2024 : 103,870,235